“Conversion surgery” for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022
Atsushi Oba(Tokyo Medical and Dental University), Yoshifumi Takeyama(Kindai University), Naoki Sasahira(The Cancer Institute Hospital), Marc G. Besselink(Amsterdam Neuroscience), Ippei Matsumoto(Kindai University), Aya Maekawa(Tokyo Medical and Dental University), Keiichi Okano(Kagawa University), Yu Takahashi(Japanese Foundation For Cancer Research), Masayuki Sho(Nara Medical University), Yoo‐Seok Yoon(Seoul National University Bundang Hospital), Yosuke Inoue(Japanese Foundation For Cancer Research), Daisuke Hashimoto(Kansai Medical University), Thomas F. Stoop(Amsterdam University of Applied Sciences), Tsutomu Fujii(University of Toyama), Marco Del Chiaro(University of Colorado Hospital), Takashi Sasaki(The Cancer Institute Hospital), Christopher L. Wolfgang(NYU Langone Health), Toshitaka Sugawara(Tokyo Medical and Dental University), Sohei Satoi(Kansai Medical University), Richard D. Schulick(University of Colorado Anschutz Medical Campus), Jin He(Johns Hopkins University), Jin‐Young Jang(Seoul National University), Yuichi Nagakawa(Tokyo Medical University), Kyoichi Takaori(Kyoto University), Minoru Tanabe(Tokyo Institute of Technology), Thilo Hackert(Universität Hamburg), Yan‐Dong Wu(Hengyang Normal University), Yuta Yoshida(Kindai University)
Cited by 28
Related Papers
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Recurrent <i>GNAS</i> Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
|Science Translational Medicine|2011|772